http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2845653-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ad95c7d046b31384a3ffb5f2d7ec7f16 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F15-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-787 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-22 |
| filingDate | 2015-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9dd610b15cec5a6b7c97a2756dd69e09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7ffa0e1f9b67c5b8bcf10bc5ed2aba1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75edd109a4dc671a033fdb70857e8f82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5dd2aa9ab209e6d3e472cdb2698cf26e |
| publicationDate | 2021-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2845653-T3 |
| titleOfInvention | Macromolecular transition metal complexes for cancer treatment and procedure for their preparation |
| abstract | Macromolecular complexes of transition metals characterized by being: (2,2'-bipyridine-4,4'-diylbis {methylene} bis (2- {2- (2-hydroxypropanoyloxy) poly (lactic acid) -yl} propanoate hexafluorophosphate ) -k2N, N ') (carbonyl) (η5-cyclopentadienyl) ruthenium (II); [(1,1 '- {1,1' - (1,1 '- {2,2'-bipyridine-4,4'-diylbis (methylene)} bis (oxy) bis (1-oxopropane-2,1 -diyl)) bis (poly (poly (lactic acid) -yl))} bis (oxy) bis (1-oxopropane-2,1-diyl) dianthracene-9-carboxylate) -k2N, N '] (carbonyl) (η5- cyclopentadienyl) ruthenium (II); [(1,1 '- {1,1' - (1,1 '- {2,2'-bipyridine-4,4'-diylbis (methylene)} bis (oxy) bis (1-oxopropane-2 , 1-diyl)) bis (poly (lactic acid) -yl))} bis (oxy) bis (1-oxopropane-2,1-diyl) dianthracene-9-carboxylate) -k2N, N '] (triphenylphosphane) ( η5-cyclopentadienyl) ruthenium (II)); [(1,1 '- {1,1' - (1,1 '- {2,2'-bipyridine-4,4'-diylbis (methylene)} bis (oxy) bis (1-oxopropane-2 , 1-diyl)) bis (poly (lactic acid) -yl))} bis (oxy) bis (1-oxopropane-2,1-diyl) dinaphthalene-2-carboxylate) -k2N, N '] (triphenylphosphane) ( η5-cyclopentadienyl) ruthenium (II); (2,2'-bipyridine-4,4'-diylbis {methylene} bis (2- {2- (2-hydroxypropanoyloxy) poly (lactic acid) -yl} propanoate) -k2N, N ') (triphenylphosphane) triflate (η5-cyclopentadienyl) ruthenium (II); [(1,1 '- {1,1' - (1,1 '- {2,2'-bipyridine-4,4'-diylbis (methylene)} bis (oxy) bis (1-oxopropan-2 , 1-diyl)) bis (poly (poly (lactic acid) -yl))} bis (oxy) bis (1-oxopropane-2,1-diyl) di (2S, 3S, 4S, 5R, 6R) -3,4 , 5,6-tetrahydroxyyoxane-2-carboxylate) -k2N, N '] (triphenylphosphane) (η5-cyclopentadienyl) -rutenium (II); [1 - ({1 - ({1- (benzyloxy) -1-oxopropane-2-yl} oxy) -1- (poly (lactic acid))} - 1-oxopropane-2-yl-4- (diphenylphosphino) benzoatok1P] (carbonyl) (iodo) (η5-cyclopentadienyl) iron (II); [tris (1- {1- (1-hydroxypropanoyloxy) poly (lactic acid) -yl} propanoate) phosphane-k1P] (carbonyl) (iodine ) (η5-cyclopentadienyl) -iron (II); or [(1 - ({1 - ({1- (benzyloxy) -1-oxopropane-2-yl} oxy) -1- (poly- (lactic acid) triflate ) 1-1-oxopropane-2-yl) -4- (diphenylphosphino) benzoate-k1P] ((2-benzoylpyridine) -k2N, O) (η5-cyclopentadienyl) ruthenium (II), and pharmacologically acceptable salts thereof. |
| priorityDate | 2014-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 266.